Results 191 to 200 of about 37,043 (306)

“I Own My Life Now”: Implications of Trauma Survivors' Language Acquisition for a Pedagogy of Empowerment in TESOL

open access: yesTESOL Quarterly, EarlyView.
Abstract This article explores the language experiences of refugees and asylum seekers who survived sex trafficking, domestic slavery, and sexuality‐based persecution. Drawing on a longitudinal study of 15 respondents followed across two time points separated by 6 years, all members of an England‐based therapeutic community, we focus here on four ...
Sally Rachel Cook, Jean Marc Dewaele
wiley   +1 more source

A Bioregional Approach to Teaching Sustainability and Resilience Online

open access: yesNew Directions for Teaching and Learning, EarlyView.
ABSTRACT This chapter describes how the first graduate program in resilient and sustainable communities has evolved over the past decade, maintaining its bioregional approach to distance learning while adapting the curriculum to meet new challenges in the age of climate change.
Laird Christensen
wiley   +1 more source

Mentoring matters to early‐career veterinarians' confidence, clinical growth and career retention: A qualitative interview study

open access: yesVeterinary Record, EarlyView.
Abstract Background Veterinarians in clinical practice, especially early‐career veterinarians and those identifying as women, have higher levels of negative mental health outcomes compared to the general population. Partnering with a mentor can mitigate some of the work‐related challenges that may contribute to poor mental health and career attrition ...
Catherine Standage   +3 more
wiley   +1 more source

The Utility of Intranasal Corticosteroids in Association With Dupilumab for Chronic Rhinosinusitis With Nasal Polyposis: A Real‐Life Multicenter Study by a Tuscany Group

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective Chronic rhinosinusitis with nasal polyps (CRSwNP) is a persistent inflammatory condition often associated with other type‐2 diseases. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has revolutionized the treatment of severe CRSwNP.
Pietro Orlando   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy